瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
瑞康医药(002589) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入610,506.25407,993.25207,302.771,231,127.781,089,671.68
营业收入610,506.25407,993.25207,302.771,231,127.781,089,671.68
二、营业总成本621,021.73418,399.48208,191.701,262,318.541,073,970.73
营业成本528,662.65354,676.93175,339.441,063,920.30906,695.28
营业税金及附加3,726.441,736.27946.475,212.724,319.42
销售费用37,553.3525,936.7510,233.8084,714.9179,727.48
管理费用33,488.3421,924.809,492.6469,991.0254,078.84
财务费用16,573.2413,498.3111,894.6836,211.8328,113.75
研发费用1,017.70626.42284.672,267.761,035.95
资产减值损失----------
公允价值变动收益-27,741.97-17,937.85-3,264.00-43,103.51-10,869.27
投资收益41,651.2131,834.905,328.83-48,111.7826,114.97
其中:对联营企业和合营企业的投资收益-------1,995.83--
汇兑收益----------
三、营业利润5,110.416,483.203,297.77-171,661.9319,603.42
加:营业外收入461.54298.74119.27110.74356.81
减:营业外支出2,245.8771.49123.392,839.971,517.85
其中:非流动资产处置损失----------
四、利润总额3,326.086,710.443,293.66-174,391.1618,442.38
减:所得税费用542.882,551.80295.31-443.893,906.11
五、净利润2,783.204,158.642,998.34-173,947.2714,536.27
归属于母公司所有者的净利润1,922.013,066.732,115.96-183,165.196,108.50
少数股东损益861.191,091.92882.399,217.928,427.77
六、每股收益
基本每股收益(元/股)0.01280.02040.0140-1.24240.0406
稀释每股收益(元/股)0.01280.02040.0140-1.24240.0406
七、其他综合收益----------
八、综合收益总额2,783.204,158.642,998.34-173,947.2714,536.27
归属于母公司所有者的综合收益总额1,922.013,066.732,115.96-183,165.196,108.50
归属于少数股东的综合收益总额861.191,091.92882.399,217.928,427.77
下载全部历史数据到excel中 返回页顶